Skip to content

Mass balance study of [14C]-VAD044

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-518843-39-00
Acronym
VAD044C003
Enrollment
7
Registered
2024-12-23
Start date
2024-12-31
Completion date
2025-03-03
Last updated
2024-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular malformation

Interventions

None listed

Sponsors

Vaderis Therapeutics AG
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026